Literature DB >> 2653150

The role of airflow resistance in patients with the adult respiratory distress syndrome.

P E Wright1, G R Bernard.   

Abstract

Although reduced lung compliance is a hallmark of the adult respiratory distress syndrome (ARDS), the role of increased airflow resistance in this disorder has not been well studied. Because animal models of ARDS show marked increases in airflow resistance and because mediators known to participate in lung parenchymal injury have also been implicated in models of increased airway reactivity, we hypothesized that increased airflow resistance is a major contributor to altered lung mechanics in human ARDS. We studied 10 mechanically ventilated patients with ARDS (criteria: PaO2 less than or equal to 70 mm Hg breathing FIO2 greater than or equal to 0.4; bilateral pulmonary roentgenographic infiltrates; Ppaw less than or equal to 18 mm Hg) measuring dynamic (Cdyn) and static (Cstat) compliance, airflow resistance across the lungs (RL), shunt fraction (QS/QT breathing FIO2 = 1.0), minute ventilation (VE), (a/A)PO2, dead space to tidal volume ratio (VD/VT), airflow (pneumotachograph), transpulmonary pressure (intratracheal pressure minus esophageal pressure) and volume (integrated from flow) at 50 L/min peak flow rate. Airflow resistance was uniformly elevated and averaged six times normal (5.32 +/- 0.92 cm H2O/L/s versus 0.88 +/- 0.08) (p less than 0.05). Cdyn correlated directly with (a/A)PO2. RL correlated with peak pressure, but did not correlate with VE, shunt, (a/A)PO2, or VD/VT. We conclude that increased pulmonary airflow resistance contributes significantly to the altered lung mechanics in ARDS. These data are consistent with studies of animal models of ARDS and long-term survivors of ARDS and may be secondary to tissue factors, airway hyperreactivity, or airway inflammation.

Entities:  

Mesh:

Year:  1989        PMID: 2653150     DOI: 10.1164/ajrccm/139.5.1169

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

1.  PEEP, ARDS, and alveolar recruitment.

Authors:  J Mancebo
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  Target blood gases during ARDS ventilatory management.

Authors:  A Pesenti
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

3.  Leukotrienes and ARDS.

Authors:  K L Brigham; J R Sheller
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 4.  Intrinsic positive end-expiratory pressure (PEEPi).

Authors:  A Rossi; G Polese; G Brandi; G Conti
Journal:  Intensive Care Med       Date:  1995-06       Impact factor: 17.440

Review 5.  Adjunctive drug treatment in severe hypoxic respiratory failure.

Authors:  S Elsasser; H Schächinger; W Strobel
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

6.  Esophageal pressures in acute lung injury: do they represent artifact or useful information about transpulmonary pressure, chest wall mechanics, and lung stress?

Authors:  Stephen H Loring; Carl R O'Donnell; Negin Behazin; Atul Malhotra; Todd Sarge; Ray Ritz; Victor Novack; Daniel Talmor
Journal:  J Appl Physiol (1985)       Date:  2009-12-17

7.  Ventilated Patients With COVID-19 Show Airflow Obstruction.

Authors:  Vikas S Koppurapu; Maksym Puliaiev; Kevin C Doerschug; Gregory A Schmidt
Journal:  J Intensive Care Med       Date:  2021-03-11       Impact factor: 3.510

Review 8.  Bench-to-bedside review: distal airways in acute respiratory distress syndrome.

Authors:  Manu Jain; J Iasha Sznajder
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

9.  Development of a multi-patient ventilator circuit with validation in an ARDS porcine model.

Authors:  Benjamin P Wankum; Riley E Reynolds; Andrea R McCain; Nathaniel T Zollinger; Keely L Buesing; Russel D Sindelar; Frank M Freihaut; Tariku Fekadu; Benjamin S Terry
Journal:  J Anesth       Date:  2021-06-01       Impact factor: 2.078

10.  Mechanical ventilation with heliox in an animal model of acute respiratory distress syndrome.

Authors:  Charlotte J Beurskens; Hamid Aslami; Friso M de Beer; Joris Jth Roelofs; Margreeth B Vroom; Nicole P Juffermans
Journal:  Intensive Care Med Exp       Date:  2014-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.